Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.

about

Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.

Item

http://www.wikidata.org/entity/Q39013857

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Determinants of Viral Oncogene ...... sk Human Papillomavirus Types.

@en

Determinants of Viral Oncogene ...... sk Human Papillomavirus Types.

@nl

type

Item

label

Determinants of Viral Oncogene ...... sk Human Papillomavirus Types.

@en

Determinants of Viral Oncogene ...... sk Human Papillomavirus Types.

@nl

prefLabel

Determinants of Viral Oncogene ...... sk Human Papillomavirus Types.

@en

Determinants of Viral Oncogene ...... sk Human Papillomavirus Types.

@nl

P1476

Determinants of Viral Oncogene ...... sk Human Papillomavirus Types.

@en

P2093

Alessandra Barca

http://www.w3.org/2001/XMLSchema#string

Anna Gillio-Tos

http://www.w3.org/2001/XMLSchema#string

Anna Iossa

http://www.w3.org/2001/XMLSchema#string

Annarosa Del Mistro

http://www.w3.org/2001/XMLSchema#string

Basilio Passamonti

http://www.w3.org/2001/XMLSchema#string

Daniela Gustinucci

http://www.w3.org/2001/XMLSchema#string

Elena Allia

http://www.w3.org/2001/XMLSchema#string

Elena Cesarini

http://www.w3.org/2001/XMLSchema#string

Giulia Fantacci

http://www.w3.org/2001/XMLSchema#string

Guglielmo Ronco

http://www.w3.org/2001/XMLSchema#string

P2860

A review of the clinical performance of the Aptima HPV assay

Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study.

Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study

Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.

Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer

Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study

Comparing the performance of six human papillomavirus tests in a screening population

P304

1056-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.01794-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28100595

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

5377832

http://www.w3.org/2001/XMLSchema#string